Cargando…
Cooperative Treatment of Gastric Cancer Using B7-H7 siRNA and Docetaxel; How Could They Modify Their Effectiveness?
PURPOSE: Despite the high prevalence of gastric cancer (GC), drug resistance is a major problem for effective chemotherapy. B7-H7 is a novel member of the B7 superfamily and is expressed in most common cancers. However, the role of B7-H7 on the aggressiveness of GC and chemosensitivity has remained...
Autores principales: | Bolandi, Nadia, Khadem Ansari, Mohammad Hassan, Rasmi, Yousef, Baradaran, Behzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460818/ https://www.ncbi.nlm.nih.gov/pubmed/37646055 http://dx.doi.org/10.34172/apb.2023.055 |
Ejemplares similares
-
The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment
por: Bolandi, Nadia, et al.
Publicado: (2021) -
siRNA-Mediated Silencing of CIP2A Enhances Docetaxel Activity Against PC-3 Prostate Cancer Cells
por: Razi Soofiyani, Saiedeh, et al.
Publicado: (2017) -
The Effect of Snail1 Gene Silencing by siRNA in Metastatic Breast Cancer Cell Lines
por: ALETAHA, Mansoor, et al.
Publicado: (2017) -
Serum Level of Xanthine Oxidase, Uric Acid, and NADPH Oxidase 1 in Stage I of Multiple Myeloma
por: Kohsari, Maryam, et al.
Publicado: (2020) -
Synthesis of siRNAs incorporated with cationic peptides R8G7 and R8A7 and the effect of the modifications on siRNA properties
por: Matsubara, Miho, et al.
Publicado: (2020)